Following several leadership changes, High Point clinical stage pharmaceutical company vTv therapeutics Inc. has named Paul Sekhri as president and chief executive officer. He joins the company as it prepares to enter Phase 3 trials for its orally delivered Type 1 Diabetes treatment.
